BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32298699)

  • 1. Distinct associations of sputum and oral microbiota with atopic, immunologic, and clinical features in mild asthma.
    Durack J; Christian LS; Nariya S; Gonzalez J; Bhakta NR; Ansel KM; Beigelman A; Castro M; Dyer AM; Israel E; Kraft M; Martin RJ; Mauger DT; Peters SP; Rosenberg SR; Sorkness CA; Wechsler ME; Wenzel SE; White SR; Lynch SV; Boushey HA; Huang YJ;
    J Allergy Clin Immunol; 2020 Nov; 146(5):1016-1026. PubMed ID: 32298699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment.
    Durack J; Lynch SV; Nariya S; Bhakta NR; Beigelman A; Castro M; Dyer AM; Israel E; Kraft M; Martin RJ; Mauger DT; Rosenberg SR; Sharp-King T; White SR; Woodruff PG; Avila PC; Denlinger LC; Holguin F; Lazarus SC; Lugogo N; Moore WC; Peters SP; Que L; Smith LJ; Sorkness CA; Wechsler ME; Wenzel SE; Boushey HA; Huang YJ;
    J Allergy Clin Immunol; 2017 Jul; 140(1):63-75. PubMed ID: 27838347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between fungal and bacterial microbiota of airways and asthma endotypes.
    Sharma A; Laxman B; Naureckas ET; Hogarth DK; Sperling AI; Solway J; Ober C; Gilbert JA; White SR
    J Allergy Clin Immunol; 2019 Nov; 144(5):1214-1227.e7. PubMed ID: 31279011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial biogeography of adult airways in atopic asthma.
    Durack J; Huang YJ; Nariya S; Christian LS; Ansel KM; Beigelman A; Castro M; Dyer AM; Israel E; Kraft M; Martin RJ; Mauger DT; Rosenberg SR; King TS; White SR; Denlinger LC; Holguin F; Lazarus SC; Lugogo N; Peters SP; Smith LJ; Wechsler ME; Lynch SV; Boushey HA;
    Microbiome; 2018 Jun; 6(1):104. PubMed ID: 29885665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The airways microbiome of individuals with asthma treated with high and low doses of inhaled corticosteroids.
    Martin MJ; Zain NMM; Hearson G; Rivett DW; Koller G; Wooldridge DJ; Rose G; Gharbia SE; Forbes B; Bruce KD; Harrison TW
    PLoS One; 2020; 15(12):e0244681. PubMed ID: 33378384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The airway microbiome in patients with severe asthma: Associations with disease features and severity.
    Huang YJ; Nariya S; Harris JM; Lynch SV; Choy DF; Arron JR; Boushey H
    J Allergy Clin Immunol; 2015 Oct; 136(4):874-84. PubMed ID: 26220531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics.
    Pragman AA; Knutson KA; Gould TJ; Hodgson SW; Isaacson RE; Reilly CS; Wendt CH
    PLoS One; 2019; 14(7):e0219962. PubMed ID: 31335912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The upper-airway microbiome as a biomarker of asthma exacerbations despite inhaled corticosteroid treatment.
    Perez-Garcia J; González-Carracedo M; Espuela-Ortiz A; Hernández-Pérez JM; González-Pérez R; Sardón-Prado O; Martin-Gonzalez E; Mederos-Luis E; Poza-Guedes P; Corcuera-Elosegui P; Callero A; Sánchez-Machín I; Korta-Murua J; Pérez-Pérez JA; Villar J; Pino-Yanes M; Lorenzo-Diaz F
    J Allergy Clin Immunol; 2023 Mar; 151(3):706-715. PubMed ID: 36343772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes.
    Baines KJ; Simpson JL; Wood LG; Scott RJ; Fibbens NL; Powell H; Cowan DC; Taylor DR; Cowan JO; Gibson PG
    J Allergy Clin Immunol; 2014 Apr; 133(4):997-1007. PubMed ID: 24582314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker-based asthma phenotypes of corticosteroid response.
    Cowan DC; Taylor DR; Peterson LE; Cowan JO; Palmay R; Williamson A; Hammel J; Erzurum SC; Hazen SL; Comhair SAA
    J Allergy Clin Immunol; 2015 Apr; 135(4):877-883.e1. PubMed ID: 25488689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids.
    Peters MC; Kerr S; Dunican EM; Woodruff PG; Fajt ML; Levy BD; Israel E; Phillips BR; Mauger DT; Comhair SA; Erzurum SC; Johansson MW; Jarjour NN; Coverstone AM; Castro M; Hastie AT; Bleecker ER; Wenzel SE; Fahy JV;
    J Allergy Clin Immunol; 2019 Jan; 143(1):104-113.e14. PubMed ID: 29524537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of inhaled corticosteroids in real life on clinical outcomes, sputum cells and systemic inflammation in asthmatics: a retrospective cohort study in a secondary care centre.
    Demarche SF; Schleich FN; Henket MA; Paulus VA; Van Hees TJ; Louis RE
    BMJ Open; 2017 Nov; 7(11):e018186. PubMed ID: 29183929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory mediators in induced sputum and airway hyperresponsiveness in cough variant asthma during long-term inhaled corticosteroid treatment.
    Liu M; Liu K; Zhu N; Xia J; Chen X
    Mediators Inflamm; 2012; 2012():403868. PubMed ID: 22927709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma.
    Hothersall EJ; Chaudhuri R; McSharry C; Donnelly I; Lafferty J; McMahon AD; Weir CJ; Meiklejohn J; Sattar N; McInnes I; Wood S; Thomson NC
    Thorax; 2008 Dec; 63(12):1070-5. PubMed ID: 18757458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaler Steroid Use Changes Oral and Airway Bacterial and Fungal Microbiome Profile in Asthma Patients.
    Oğuzülgen K; Öztürk AB; Bacceoğlu A; Aydın Ö; Köycü Buhari G; Damadoğlu E; Öner Erkekol F; Göksel Ö; Karakaya G; Kalyoncu AF; Kalpaklıoğlu F; Mungan D; Türktaş H; Pur Özyiğit L; Ergin Ç; Erdoğan M; Kalkancı A
    Int Arch Allergy Immunol; 2024; 185(1):10-19. PubMed ID: 37844548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atopic asthmatic immune phenotypes associated with airway microbiota and airway obstruction.
    Turturice BA; McGee HS; Oliver B; Baraket M; Nguyen BT; Ascoli C; Ranjan R; Rani A; Perkins DL; Finn PW
    PLoS One; 2017; 12(10):e0184566. PubMed ID: 29053714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of asthma resistant to moderate dose inhaled corticosteroid treatment on bronchial hyperresponsiveness.
    Fujimoto K; Yamaguchi S; Urushibata K; Hanaoka M; Koizumi T; Honda T; Kubo K
    Intern Med; 2006; 45(14):843-9. PubMed ID: 16908940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of symptom recurrence after low-dose inhaled corticosteroid cessation in mild persistent asthma.
    Tonelli M; Bacci E; Dente FL; Bartoli ML; Cianchetti S; Di Franco A; Vagaggini B; Zingoni M; Paggiaro PL
    Respir Med; 2006 Apr; 100(4):622-9. PubMed ID: 16253493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. House dust microbiota in relation to adult asthma and atopy in a US farming population.
    Lee MK; Wyss AB; Carnes MU; Richards M; Parks CG; Beane Freeman LE; Thorne PS; Umbach DM; Azcarate-Peril MA; Peddada SD; London SJ
    J Allergy Clin Immunol; 2021 Mar; 147(3):910-920. PubMed ID: 32615170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sputum microbiome profiles identify severe asthma phenotypes of relative stability at 12 to 18 months.
    Abdel-Aziz MI; Brinkman P; Vijverberg SJH; Neerincx AH; Riley JH; Bates S; Hashimoto S; Kermani NZ; Chung KF; Djukanovic R; Dahlén SE; Adcock IM; Howarth PH; Sterk PJ; Kraneveld AD; Maitland-van der Zee AH;
    J Allergy Clin Immunol; 2021 Jan; 147(1):123-134. PubMed ID: 32353491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.